Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Korea United Pharm. Inc. clinical trials
Also known as 한국유나이티드제약.
The registry lists 21 studies whose lead sponsor is Korea United Pharm. Inc.. 5 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jul 29, 2026.
Keep track of what changes. Save the Korea United Pharm. Inc. studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesWhere
- Korea, Republic of
- 15
Registry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Korea United Pharm. Inc..
- Korea United Pharm. Inc.21 studiesSame company
Something wrong?
Studies
Recruiting first, then most recently updated. Showing 21 of 21.
- Safety, PK, and PD Comparison of UI059 and UIC202201 in Healthy VolunteersNot yet recruitingNCT07727629Phase 1
- A Randomized, Open-label, Two-arm, Two-period, Multiple-dose, Study to Evaluate Pharmacokinetic Drug-drug Interaction, Safety and Tolerability of UIC202601 and UIC202602 in Healthy VolunteersRecruitingNCT07682948Phase 1
- A Study to Evaluate the Safety and Pharmacokinetics of UI087 Compared to Coadministration of UIC202506, UIC202507 and UIC202508 in Healthy Adult Volunteers Under Fasting ConditionsNot yet recruitingNCT07548957Phase 1
- A Two-arm, Open-label, Single-sequence, Multiple-dose, Cross-over Study to Evaluate the Pharmacokinetic Interaction and the Safety of UIC202502 and UIC202505 in Healthy Adult VolunteersRecruitingNCT07162441Phase 1
- A Study to Compare and Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of UI059 and UIC202201Not yet recruitingNCT06393881Phase 1
- Drug-drug Interaction Study Between UIC202304, and UIC202305CompletedNCT07735052Phase 1
- Study to Evaluate the Safety and the Pharmacokinetics of "UI111" and "UIC202006" Under Fed ConditionsCompletedNCT07691268Phase 1
- A Study to Evaluate the Efficacy and Safety of UI022/UI023CompletedNCT07600385Phase 3
- Bioequivalence Study Between UI009 and UIC202005 in Healthy SubjectsCompletedNCT07110740Phase 1
- Drug-drug Interaction Study Between UIC201603, and UIC201604CompletedNCT06568133Phase 1
- A Study to Compare PK, PD and Safety of UI058 and UIC202004 in Healthy SubjectsCompletedNCT05282914Phase 1
- A Clinical Study to Evaluate the Safety and the Pharmacokinetics of UI068 in Healthy Adult Volunteers Under Fed ConditionsCompletedNCT06141590Phase 1
- A Study to Compare Pharmacokinetics, Pharmacodynamics and Safety of UI059 and UIC202201 in Healthy SubjectsCompletedNCT06141577Phase 1
- Drug-drug Interaction Study Between UIC201601 and UIC201602CompletedNCT05190133Phase 1
- Study to Evaluate the Safety and PK of UI018Status unknownNCT05085184Phase 1
- Arformoterol/Budesonide for COVID-19Status unknownNCT05055414Phase 2
- Safety and Efficacy of Cefecin Tab. in Patients With Acute SinusitisTerminatedNCT04664803Phase 4
- Efficacy and Safety of UI05MSP015CT in Functional DyspepsiaCompletedNCT03225248Phase 3
- A Randomized, Open-label, Single Dose, Two-way Crossover Clinical Trial to Compare the Safety, Pharmacokinetic Profiles of UI15AML055MT and Amosartan® Tablet 5/50 mg After a Single Oral Administration in Healthy Male VolunteersCompletedNCT02166398Phase 1
- Safety and Efficacy of KALOMIN™ Tab. in Patients With Acute BronchitisCompletedNCT02151734Phase 3
- Pharmacokinetics and Food Effect of Sarpogrelate HCl CR Formulation in Comparison to Immediate-release FormulationCompletedNCT01841086Phase 1